All Breast cancer articles
-
NewsMHRA approves licence extension for breast cancer drug alpelisib
The drug can now be used in combination with fulvestrant to treat hormone receptor positive, human epidermal growth factor receptor 2-negative, locally advanced or metastatic breast cancer with a PIK3CA mutation in men and postmenopausal women
-
News
UK researchers find way to boost emerging breast cancer drug’s effectiveness
Augmenting investigational drug xentuzumab could boost oestrogen receptor-positive breast cancer cell death, according to new findings
-
News
NICE recommends abemaciclib for advanced breast cancer
New draft guidance from NICE recommends twice-daily abemaciclib with fulvestrant for adults with hormone receptor-positive, HER2-negative breast cancer
-
NICE guideline
NICE breast cancer guideline
An easy-to-read NICE guidance summary on the classification and care of people at risk of familial breast cancer or with a family history of breast cancer.
-
Independent professional body guideline
Cancer referral guideline
This easy-to-use summary covers the recognition, referral, and investigation of people who may have cancer.
